IL10 and metabolic dysfunction-associated steatohepatitis: The levels of IL-10 in liver tissue were not significantly different between the compared groups (p = 0.162), but the post-test showed a significantly higher median value in CHC-NSF in comparison with NASH (p < 0.05).